Activation of c-fos expression in hypothalamic nuclei by μ- and κ-receptor agonists: Correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus

Endocrinology

Volumn 141, Issue 4, 2000, Pages 1366-1376

  Laorden, M L ^a   Castells, M T ^a   Martinez M D ^a   Martinez P J ^a   Milanes M V ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; NORADRENALIN; NORBINALTORPHIMINE; PROTEIN C FOS; SODIUM CHLORIDE;

ADRENAL CORTEX; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE; NERVE PROJECTION; NONHUMAN; NORADRENERGIC NERVE; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SENSORY NERVE; THALAMUS MIDLINE NUCLEUS;

EID: 0034456580     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.4.7407     Document Type: Article

References (59)

1. The use of c-fos as a metabolic marker in neuronal pathways tracing
2. Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun
3. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system
4. Differences in hypothalamic-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine
5. Effects of opioids on the hypothalamo-pituitary-adrenal axis
6. Effects of specific μ and κ opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat
7. Effects of acute and chronic administration of μ and δ-opioid agonists on the hypothalamic-pituitary-adrenocortical (HPA) axis in the rat
8. Plasma β-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal
9. Pituitary-adrenocortical response to acute and chronic administration of U-50,488H in the rat
10. Intracerebroventricular administration of β-endorphin increases the expression of c-fos and of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus of the rat
11. Pharmacological characterization of opioid receptor influencing the secretion of corticotrophin-releasing factor in the rat
12. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats
13. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: Implication of α- and β-adrenoceptors
14. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: Correlations with hypothalamic noradrenergic activity and pituitary-adrenal response
15. Morphine activation of c-Fos expression in rat brain
16. 1 and N-methyl-D-aspartate receptors
17. Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats
18. Differential effects of μ and κ opioid antagonists on Fos-like immunoreactivity in extended amygdala
19. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat
20. Pattern and time course of immediate-early gene expression in rat brain following acute stress
21. Different programs of gene expression are associated with different phases of the 24 hr and sleep-wake cycles
22. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat
23. Isolated removal of hypothalamic or other brain nuclei of the rat
24. 3-Methoxy-4-hydroxyphenylethyleneglycol concentrations in discrete hypothalamic nuclei reflect the activity of noradrenergic neurons
25. Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs
26. Hypothalamic regulation of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor
27. Neuroendocrine responses to an emotional stressor: Evidence for involvement of the medial but not the central amygdala
28. Hypothalamic effector neurons and extended circuitries activated in "neurogenic" stress: A comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoids levels
29. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunocitochemical study
30. Pattern of c-fos mRNA induction in rat brain by acute morphine
31. FOS expression induced by interleukin-1 or acute morphine treatment in the rat hypothalamus is attenuated by chronic exposure to morphine
32. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection
33. Structure-function of the cloned opiate receptors: Peptide and small molecule interactions
34. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain
35. Novel environment induced inhibition of corticosterone secretion: Physiological evidence for a suprachiasmatic nucleus mediated neuronal hypothalamo-adrenal cortex pathway
36. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications
37. Physiological mechanisms regulating photic induction of Fos-like protein in hamster suprachiasmatic nucleus
38. Spontaneous rhythm in c-Fos immunoreactivity in the dorsomedial part of the rat suprachiasmatic nucleus
39. Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons
40. + currents in magnocellular neurons of the supraoptic nucleus in rat
41. Opioid and cannabinoid receptor inhibition of adenyl cyclase in brain
42. Opioids excite dopamine neurons by hyperpolarization of local interneurons
43. Transcriptional regulation by extracellular signals: Mechanisms and specificity
44. Opioid effects on mitogen-activated protein kinase signaling cascades
45. Molecular and cellular basis of addiction
46. A comparison of two immediate-early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry
47. Early induction of c-fos precedes increased expression of corticotropin-releasing factor mRNA in the paraventricular nucleus after immobilization stress
48. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level
49. Role of alpha adrenergic mechanisms in effects of morphine on the hypothalamopituitary-adrenocortical and cardiovascular systems in the rat
50. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus
51. Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: Effects of catecholamines
52. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats
53. 2+ channel ligands modulate morphine effects on the hypothalamus-pituitary-adrenocortical axis in rat
54. Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons
55. The corticotropin-releasing factor system
56. c-Fos as a transcription factor: A stressful (re)view from a functional map